3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Lung Neoplasms
11
Head and Neck Neoplasms
5
Breast Neoplasms
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma
2
Brain Neoplasms
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Untreated Childhood Anaplastic Astrocytoma
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Salivary Gland Neoplasms
1
Recurrence
1
Pleural Effusion, Malignant
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Interventions
Ifosfamide
11
Methotrexate
9
Doxorubicin
7
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Cisplatin
6
Leucovorin
5
Etoposide
5
X-Rays
4
Specimen Handling
4
Sirolimus
4
Phantoms, Imaging
4
Gemcitabine
4
temsirolimus
3
sargramostim
3
dinutuximab
3
cixutumumab
3
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Dexrazoxane
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
samarium Sm-153 lexidronam
2
palbociclib
2
olaparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Osteosarcoma
×
Gefitinib
×
Clear all
No trials found.